Class IIOngoingD-0166-2025
Drug recall · January 1, 2025
UMARY ACID HYALURONIC recall
Why: cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
- Lots / codes
Lot#: 24183, Exp 07/01/28
- Quantity
- 321 bottles
- Company
- Mxbbb, El Paso, TX
- Distribution
- Product was sold via Amazon Marketplace.
- Initiated
- November 14, 2024 · Voluntary: Firm initiated
- Classified
- December 26, 2024
- Reported
- January 1, 2025
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.